Skip to main content
HR 6160 117th Congress House Health Health care costs and insurance Health care coverage and access Medicaid Medicare Prescription drugs

Access to Rare Indications Act of 2021

Introduced: December 7, 2021 Introduced by: Matsui, Doris O. Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 8, 2021
Referred to the Subcommittee on Health.
Dec 7, 2021
Introduced in House
Dec 7, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Access to Rare Indications Act of 2021

This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.

What's happening now December 8, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 7
All 7 Democratic 3 Republican 2
D
Sherrill, Mikie
New Jersey · Nov 29, 2022
 D
Evans, Dwight
Pennsylvania · Oct 7, 2022
 D
Stansbury, Melanie A.
New Mexico · Jul 7, 2022
 R
Fitzpatrick, Brian K.
Pennsylvania · Feb 18, 2022
 R
Kelly, Mike
Pennsylvania · Dec 7, 2021
Mullin, Markwayne
· Dec 7, 2021
 D
Thompson, Mike
California · Dec 7, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6160: Access to Rare Indications Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6160/
MLA
"H.R. 6160: Access to Rare Indications Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6160/.
Bluebook (legal)
H.R. 6160, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6160/.
Markdown link
[H.R. 6160: Access to Rare Indications Act of 2021](https://openamerica.io/bill/117-HR-6160/)
Report a problem